Study guide

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism

Key Takeaways Explain This Topic AI

Severe thermal trauma involving ≥40% Total Body Surface Area (TBSA) induces the most extreme catabolic and hypermetabolic state recognized in clinical medicine, with resting energy expenditure (REE) increasing up to 100% to 140% above baseline.

Cuthbertson's biphasic paradigm defines two distinct metabolic stages: the initial hypometabolic Ebb Phase (first 24–48 hours) characterized by cellular hypoperfusion and depressed VO2, followed by the prolonged hypermetabolic Flow Phase (days to 1–2 years) marked by supranormal cardiac output, severe skeletal muscle proteolysis, and futile substrate cycling.

A sustained baseline core body temperature reset to 38.0°C–38.5°C (100.4°F–101.3°F) is an expected physiologic feature of the flow phase driven by hypothalamic cytokine-prostaglandin signaling and mitochondrial uncoupling, and should not be reflexively treated as isolated sepsis without corroborating diagnostic evidence.

The hypermetabolic response is driven by 10- to 50-fold sustained elevations in circulating catecholamines (epinephrine, norepinephrine), cortisol, and glucagon, alongside a severe systemic pro-inflammatory cytokine cascade (IL-1β, IL-6, TNF-α).

Without aggressive anti-catabolic pharmacotherapy, environmental thermoregulation, and nutritional support, post-burn hypermetabolism peaks at 7–10 days post-injury and can persist for up to 24 months, leading to profound loss of lean body mass, immunodeficiency, and delayed rehabilitation.

Last updated: August 2026

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism

Core Knowledge: Major burn trauma involving ≥ 40% Total Body Surface Area (TBSA) triggers the most severe, prolonged, and life-threatening hypermetabolic response known in clinical medicine. Resting Energy Expenditure (REE) in severe burns can surge to 100% to 140% above normal basal values—a metabolic demand that dwarfs other critical illnesses such as severe sepsis (+30% to 50%), major polytrauma (+20% to 40%), or major elective surgery (+10% to 20%). Mastering the physiological trajectory from the initial hypometabolic ebb phase to the chronic hypermetabolic flow phase is essential for Certified Burn Registered Nurses (CBRN) to deliver tailored resuscitation, metabolic support, and targeted anti-catabolic therapies.

1. Magnitude and Overview of Post-Burn Hypermetabolism

Thermal destruction of the cutaneous barrier initiates a systemic neuroendocrine, inflammatory, and oxidative stress storm. In burns encompassing ≥ 20% TBSA, this reaction ceases to be a localized wound phenomenon and evolves into a generalized hypermetabolic crisis affecting every organ system. COMPARATIVE PEAK RESTING ENERGY EXPENDITURE (REE)

  • ┌──────────────────────────────────────────────┬──────────────────────────┐
  • │ Clinical Condition │ Elevation Above Basal REE│
  • ├──────────────────────────────────────────────┼──────────────────────────┤
  • │ Normal Healthy Basal State │ Baseline (0%) │
  • │ Major Elective Abdominal Surgery │ +10% to +20% │
  • │ Severe Skeletal Polytrauma │ +20% to +40% │
  • │ Severe Sepsis / Septic Shock │ +30% to +50% │
  • │ Major Burn Trauma (≥40% TBSA) │ +100% to +140% │
  • └──────────────────────────────────────────────┴──────────────────────────┘

Without therapeutic intervention, massive thermal injury consumes endogenous carbohydrate, lipid, and protein stores at an alarming rate. A critically ill burn patient can lose up to 20% to 25% of total body protein mass within the first three weeks of injury. This rapid degradation of skeletal muscle and visceral organs leads to diaphragmatic weakness, failure to wean from mechanical ventilation, impaired wound healing, failure of skin autografts, immune paralysis, and multi-organ dysfunction syndrome (MODS).

2. Cuthbertson's Biphasic Metabolic Paradigm

In 1942, Sir David Cuthbertson first described the metabolic response to severe traumatic injury, dividing it into two distinct phases: the Ebb Phase and the Flow Phase . CUTHBERTSON'S BIPHASIC METABOLIC PARADIGM

  • ┌────────────────────────────────────────┬────────────────────────────────────────┐
  • │ EBB PHASE │ FLOW PHASE │
  • │ (First 24 to 48 Hours) │ (Days to Months / Years) │
  • ├────────────────────────────────────────┼────────────────────────────────────────┤
  • │ • Metabolic Rate: Hypometabolic (low) │ • Metabolic Rate: Hypermetabolic (high)│
  • │ • Oxygen Consumption (VO2): Decreased │ • Oxygen Consumption (VO2): Supranormal│
  • │ • Cardiac Output: Depressed (30–50%) │ • Cardiac Output: 1.5–2.5x normal │
  • │ • Core Temperature: Hypothermia risk │ • Core Temperature: Reset to 38.0–38.5C│
  • │ • Systemic Vascular Tone: Intense spasm│ • Systemic Vascular Tone: Vasodilation │
  • │ • Substrate Mobilization: Glycogenolysis│ • Substrate Mobilization: Proteolysis, │
  • │ predominates │ Lipolysis, Gluconeogenesis │
  • │ • Primary Clinical Priority: Volume │ • Primary Clinical Priority: Metabolic │
  • │ resuscitation and tissue perfusion │ support, nutrition, anti-catabolism │
  • └────────────────────────────────────────┴────────────────────────────────────────┘
  • The Hypometabolic Ebb Phase (0 to 48 Hours Post-Burn)

The ebb phase corresponds directly to the acute burn shock period:

Cellular Hypoxia & Depressed Energetics: Intravascular hypovolemia, massive capillary leak, and intrinsic myocardial depression lead to a precipitous drop in cardiac output (often 30% to 50% below baseline). Total body oxygen consumption (VO2) and resting energy expenditure drop significantly below basal levels.

Hypothermia: Impairment of central thermal autoregulation, massive evaporative heat loss across open burn wounds (0.58 kcal lost per mL of evaporated water), and peripheral hypoperfusion place the patient at severe risk for hypothermia (<36.0°C / <96.8°F).

Early Hyperglycemia: Even in this hypometabolic state, initial catecholamine and cortisol spikes stimulate rapid hepatic glycogenolysis, leading to early stress-induced elevations in serum glucose despite cellular starvation.

The Hypermetabolic Flow Phase (>48 to 72 Hours to 1–2 Years)

As capillary integrity is restored, fluid shifts stabilize, and resuscitation volume is resorbed, the patient enters the prolonged flow phase:

Hyperdynamic Cardiovascular State: Cardiac output surges to 150% to 250% of normal baseline (cardiac indices frequently reaching 4.5 to 7.0 L/min/m^2, with heart rates of 110 to 140 bpm).

Elevated Core Temperature Setpoint: The hypothalamic thermal setpoint is reset upward to 38.0°C to 38.5°C (100.4°F to 101.3°F) . This elevation is driven by circulating pyrogenic cytokines (IL-1, IL-6, TNF-alpha) and uncoupled mitochondrial thermogenesis in brown/beige adipose tissue. In the absence of leukocytosis, worsening base deficit, or localized wound changes, this baseline fever reflects pure hypermetabolism rather than acute sepsis.

Profound Muscle Proteolysis: Skeletal muscle protein is rapidly hydrolyzed to supply free amino acids (alanine and glutamine) for hepatic gluconeogenesis and the synthesis of acute-phase reactant proteins.

3. Neuroendocrine and Inflammatory Drivers of Hypermetabolism

The post-burn hypermetabolic storm is orchestrated by a complex interplay of endocrine hormones and pro-inflammatory cytokines: THE BURN HYPERMETABOLIC CASCADE

  • ┌─────────────────────────────────────────────────────────────────────────────┐
  • │ Thermal Injury (≥20–40% TBSA) & Tissue Necrosis │
  • └──────────────────────────────────────┬──────────────────────────────────────┘
  • │
  • ▼
  • ┌─────────────────────────────────────────────────────────────────────────────┐
  • │ Massive Sympathoadrenal & Hypothalamic-Pituitary-Adrenal (HPA) Activation │
  • ├──────────────────────────────────────┬──────────────────────────────────────┤
  • │ • Catecholamines (Epi/Norepi) ↑ 10–50x│ • Pro-inflammatory Cytokines: │
  • │ • Cortisol ↑ 3–5x │ TNF-α, IL-1β, IL-6, IL-8 │
  • │ • Glucagon ↑ 2–4x │ • Mitochondrial Uncoupling (UCP-1) │
  • └──────────────────────────────────────┬──────────────────────────────────────┘
  • │
  • ┌───────────────────────────────┴───────────────────────────────┐
  • ▼ ▼
  • ┌──────────────────────────────┐ ┌──────────────────────────────┐
  • │ SKELETAL MUSCLE │ │ ADIPOSE TISSUE │
  • │ • Massive proteolysis │ │ • Unchecked lipolysis (HSL) │
  • │ • Alanine / Glutamine efflux │ │ • FFA & Glycerol release │
  • │ • Severe wasting & cachexia │ │ • White-to-brown browning │
  • └──────────────┬───────────────┘ └──────────────┬───────────────┘
  • │ │
  • └───────────────────────────────┬─────────────────────────────┘
  • │
  • ▼
  • ┌──────────────────────────────┐
  • │ LIVER (CORE) │
  • │ • Uncontrolled Gluconeogenesis│
  • │ • Accelerated Cori Cycling │
  • │ • Acute-Phase Reactant Synth │
  • │ • Severe Hepatic Steatosis │
  • └──────────────────────────────┘
  • 1. Catecholamine Storm (Epinephrine & Norepinephrine)

Plasma catecholamines rise 10- to 50-fold above normal within hours of severe thermal trauma and remain elevated for months. Catecholamines are the primary drivers of tachycardia, hyperdynamic cardiac output, peripheral lipolysis via hormone-sensitive lipase (HSL), and increased resting energy expenditure.

2. Glucocorticoids (Cortisol)

Serum cortisol levels rise 3- to 5-fold and remain persistently elevated due to chronic hypothalamic-pituitary-adrenal (HPA) axis stimulation. Cortisol accelerates skeletal muscle proteolysis, promotes central osteopenia, downregulates insulin receptor sensitivity, and inhibits fibroblast proliferation.

3. Glucagon

Elevated 2- to 4-fold, glucagon shifts the insulin-to-glucagon ratio toward severe catabolism, stimulating hepatic glycogenolysis and continuous gluconeogenesis.

4. Pro-Inflammatory Cytokines

Interleukin-6 (IL-6): The primary mediator of the hepatic acute-phase response, stimulating the production of C-reactive protein (CRP), ferritin, and fibrinogen while suppressing constitutive protein synthesis (albumin, prealbumin, transferrin).

Tumor Necrosis Factor-alpha (TNF-alpha) & IL-1beta: Inhibit muscle protein synthesis, induce anorexia, stimulate endothelial adhesion molecules, and disrupt sarcoplasmic calcium handling.

4. Futile Substrate Cycling and Metabolic Inefficiency

A central hallmark of post-burn hypermetabolism is futile substrate cycling —biochemical pathways where substrates are simultaneously synthesized and degraded without producing useful cellular work, dissipating large amounts of energy as heat.

Futile Metabolic Cycle Mechanism and Energetic Cost Clinical Manifestation in Burns

Cori Cycle (Glucose-Lactate-Glucose) Anaerobic glycolysis in hypoxic burn wound tissue converts glucose into lactate. The liver clears lactate and converts it back into glucose via gluconeogenesis at a net cost of 6 ATP molecules per cycle . Continuous hepatic glucose output, refractory stress hyperglycemia, elevated plasma lactate levels despite adequate systemic oxygenation.

Triglyceride-Fatty Acid Cycle Hormone-sensitive lipase hydrolyzes triglycerides in adipose tissue into free fatty acids (FFAs) and glycerol. The liver re-esterifies up to 70% of these FFAs back into triglycerides at high ATP cost. Massive peripheral fat mobilization, loss of subcutaneous fat stores, severe hepatic steatosis (fatty liver), and hepatomegaly.

Adipose Tissue Browning (UCP-1) Sustained high circulating catecholamines stimulate beta-3 adrenergic receptors on subcutaneous white adipocytes, inducing transformation into beige/brown adipose tissue expressing Uncoupling Protein 1 (UCP-1) . Mitochondria uncouple oxidative phosphorylation from ATP synthesis, dissipating the proton gradient entirely as heat, exacerbating hypermetabolic energy expenditure.

Protein Proteolysis & Resynthesis Skeletal muscle is broken down into free amino acids; while some are utilized for acute-phase proteins and wound healing, substantial quantities are deaminated and lost in the urine. Severe negative nitrogen balance, skeletal muscle sarcopenia, profound physical weakness, and loss of functional independence.

5. Timeline and Chronicity of the Hypermetabolic Response

Post-burn hypermetabolism is not a transient acute-phase reaction; it represents a chronic, debilitating pathophysiological state:

Onset: Transitions from the ebb phase into the flow phase between 48 and 72 hours post-injury .

Peak: Resting energy expenditure and protein catabolism reach their zenith between post-burn days 7 and 10 .

Duration: In burns ≥ 40% TBSA, hypermetabolism, abnormal heart rate variability, peripheral insulin resistance, and osteopenia persist for 12 to 24 months post-injury , long after full cutaneous wound closure has been achieved. CHRONIC TRAJECTORY OF POST-BURN HYPERMETABOLISM

  • REE (% above normal)
  • 140% ┼ ╭─────╮ (Peak: Day 7–10)
  • 120% ┼ ╭╯ ╰╮
  • 100% ┼ ╭╯ ╰──────╮
  • 80% ┼ ╭╯ ╰──────────╮
  • 60% ┼ ╭╯ ╰───────────╮
  • 40% ┼ ╭╯ ╰────────╮
  • 20% ┼ Ebb Phase │ ╰──────
  • 0% ┼───╲___________╱──────────────────────────────────────────────────────────
  • 0 24h 48h Day 7 Day 14 Month 1 Month 6 Month 12 Month 24

Important

Because the flow phase persists for up to two years, rehabilitation, aggressive high-protein nutritional support, resistive exercise programs, and anti-catabolic pharmacotherapies must continue well past hospital discharge into long-term outpatient recovery.